Interact to see
Advertisement
Advertisement
CBACX vs PASCX
CBACX vs PASCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CBACX vs. PASCX commentary
Jul 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBACX is a Buy and PASCX is a Hold.
FUNDAMENTALS
Fundamentals
PASCX has more cash in the bank: 11.1B vs. CBACX (163M). PASCX pays higher dividends than CBACX: PASCX (5.06) vs CBACX (1.22). CBACX was incepted earlier than PASCX: CBACX (32 years) vs PASCX (22 years). PASCX (3.15) is less costly to investors than CBACX (2.19). PASCX is a more actively managed with annual turnover of: 40.00 vs. CBACX (38.00). PASCX has a lower initial minimum investment than CBACX: PASCX (1000) vs CBACX (2500). PASCX annual gain was more profitable for investors over the last year : 5.08 vs. CBACX (-7.33). PASCX return over 5 years is better than : 30.53 vs. CBACX (12.51).
| CBACX | PASCX | CBACX / PASCX | |
| Total Expense Ratio | 2.18 | 3.06 | 71% |
| Annual Report Gross Expense Ratio | 2.19 | 3.15 | 70% |
| Fund Existence | 32 years | 22 years | - |
| Gain YTD | 6.530 | 5.900 | 111% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 163M | 11.1B | 1% |
| Annual Yield % from dividends | 1.22 | 5.06 | 24% |
| Returns for 1 year | -7.33 | 5.08 | -144% |
| Returns for 3 years | -2.01 | 17.42 | -12% |
| Returns for 5 years | 12.51 | 30.53 | 41% |
| Returns for 10 years | 23.56 | 49.40 | 48% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VSFIX | 24.21 | N/A | N/A |
| Federated Hermes Clover Small Value IS | |||
| MSDMX | 14.09 | N/A | N/A |
| Morgan Stanley Emerging Mkt ex China R6 | |||
| HIGJX | 21.19 | N/A | N/A |
| Carillon Eagle Growth & Income I | |||
| VEIGX | 37.75 | N/A | N/A |
| Vanguard Global ESG Select Stk Investor | |||
| JHBCX | 66.36 | N/A | N/A |
| JHancock Blue Chip Growth NAV | |||